-
St. Louis University is enrolling people between 12 and 50 years old to participate in a clinical trial to test if the mpox vaccine works as well in teens as it does in adults. The federal government has approved the vaccine for emergency use in minors, but it hasn’t given full approval.
-
Millions received the COVID-19 vaccine, which was the first widely used immunization to use mRNA technology. Washington University researchers hope they can use the same method to make an mRNA flu shot.
-
Washington University scientists are conducting a clinical trial of a new version of the original Moderna COVID-19 vaccine. Researchers say it will likely be better suited to newer BA.4 and BA.5 variants of the virus that have become dominant this summer.
-
As the COVID-19 death toll continues to climb, Washington University scientists are testing whether lab-engineered proteins known as monoclonal antibodies can be used to treat the illness.
-
Siteman Cancer Center’s newest location will bring access to new treatments and clinical trials to the Metro East.The cancer center's Shiloh, Illinois,…
-
In 2009, when Sheila McGlown began battling metastatic breast cancer at the age of 43, she was already a skilled fighter. She’d spent 25 years in the U.S.…
-
African-Americans have lower levels of a key protein associated with Alzheimer's disease, which could keep blacks with the disease from being diagnosed,…
-
For years, clinical trials were focused in academic medical centers such as the one below oncologist John DiPersio’s office at Siteman Cancer Center, high…
-
This article first appeared in the St. Louis Beacon, July 31, 2009 - Two cancer patients, one male, one female, get the same treatment. The results should…